Sunho Biologics, Inc. (02898) Announces Monthly Return, Authorized Capital Maintained at USD 100,000
Bulletin Express
Nov 03
Sunho Biologics, Inc. (02898) published its monthly return as of 31 October 2025. The authorized share capital stands at 200,000,000 ordinary shares, each with a par value of USD 0.0005, totaling USD 100,000. No changes were reported in these figures during the month.
The number of issued shares remains at 156,666,800, with no treasury shares on record. No share options, warrants, convertibles, or other arrangements to issue new shares were disclosed. The document was submitted on 03 November 2025 by the company’s chairman and executive director, underscoring the stability of the equity structure during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.